MONDAY, Sept. 20, 2021 (HealthDay News) — Pregnant women infected with certain strains of human papillomavirus (HPV) may have a heightened risk of preterm birth, a new study suggests. HPV is a sexually transmitted disease that can cause genital warts. Most of the time, the immune system clears the infection.Continue Reading

THURSDAY, Sept. 16, 2021 (HealthDay News) — The number of U.S. infants born with syphilis is climbing at an alarming pace, reaching a high not seen since the 1990s, according to new government figures. Newborn syphilis, a potentially fatal condition, was at one time nearly eliminated in the United States.Continue Reading

WEDNESDAY, Sept. 8, 2021 (HealthDay News) — People with HIV have an increased risk of sudden cardiac death, a new study warns, especially if the virus isn’t well-controlled. Sudden cardiac death occurs when the heart unexpectedly stops beating, usually due to an abrupt electrical malfunction. “People living with HIV areContinue Reading

FRIDAY, Sept. 3, 2021 (HealthDay News) — Transgender people have double the odds of dying early compared to folks whose identity matches the sex they were assigned at birth (cisgender), a long-term study finds. And the added risk did not decrease over time, according to an analysis of data collectedContinue Reading

MONDAY, Aug. 16, 2021 (HealthDay News) — COVID-19 vaccination triggers a strong immune response in people with HIV, meaning they’re likely protected against the coronavirus, a new, small study shows. “Previous research has suggested a suboptimal response to COVID-19 vaccines in people living with HIV; however, these studies did notContinue Reading

THURSDAY, Aug. 12, 2021 (HealthDay News) — When the antiretroviral regimen known as pre-exposure prophylaxis, or PrEP, was launched nearly a decade ago, patients were suddenly able to achieve near-complete protection against contracting HIV by taking just one pill a day. But there’s a big hitch: Not everyone is equallyContinue Reading

THURSDAY, Aug. 5, 2021 (HealthDay News) — The two HIV prevention drugs available in the United States are equally safe and effective, and the biggest difference between them is price, a new study contends. However, a sizable minority of patients have switched from the older and cheaper “preexposure prophylaxis” (PrEP)Continue Reading